Cell and Gene Therapy Training Course

Course Overview

The Cell and Gene Therapy Training Course is a comprehensive professional development program designed to equip physicians, surgeons, oncologists, hematologists, geneticists, molecular biologists, laboratory scientists, biomedical researchers, pharmacists, biotechnology professionals, healthcare IT professionals, health informatics specialists, clinical researchers, hospital administrators, regulatory professionals, and policymakers with the knowledge and practical skills required to develop, implement, and manage cell and gene therapy programs in modern healthcare. As healthcare organizations increasingly adopt cell therapy, gene therapy, CRISPR gene editing, stem cell technologies, regenerative medicine, precision medicine, genomic medicine, artificial intelligence (AI), bioinformatics, Electronic Health Records (EHRs), healthcare analytics, digital therapeutics, and cloud computing, cell and gene therapies are transforming the treatment of genetic disorders, cancer, autoimmune diseases, and rare diseases. This course provides practical methodologies for integrating advanced therapeutic technologies into healthcare systems to improve patient outcomes, clinical innovation, translational research, and organizational excellence.

Participants will gain an in-depth understanding of cellular biology, molecular genetics, gene transfer technologies, viral and non-viral vectors, stem cell therapies, CAR-T cell therapy, genome editing, regenerative medicine, immunotherapy, precision diagnostics, biomarker discovery, translational medicine, clinical bioinformatics, manufacturing processes, quality control, and advanced therapeutic medicinal products (ATMPs). The course explores applications of cell and gene therapy in oncology, hematology, neurology, cardiology, ophthalmology, inherited genetic diseases, immunological disorders, regenerative medicine, and personalized healthcare while emphasizing integration with Laboratory Information Systems (LIS), Electronic Health Records, Health Information Exchange (HIE), cloud-based healthcare platforms, and clinical decision support systems. Practical exercises demonstrate therapeutic workflow development, manufacturing quality management, genomic analysis, treatment planning, and evidence-based clinical implementation.

The training further explores emerging technologies including artificial intelligence-assisted therapeutic development, machine learning, digital twins, CRISPR-Cas systems, induced pluripotent stem cells (iPSCs), organoid technologies, three-dimensional bioprinting, blockchain-enabled healthcare data security, Internet of Medical Things (IoMT), cloud-native bioinformatics, healthcare cybersecurity, interoperability standards including HL7, FHIR, and DICOM, biosafety, ethical governance, regulatory compliance, and international best practices. Participants will examine Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), laboratory accreditation, patient safety, informed consent, healthcare governance, commercialization strategies, reimbursement models, implementation frameworks, and organizational readiness necessary for successful deployment of cell and gene therapy programs.

Upon successful completion of this course, participants will possess the competencies required to evaluate, design, implement, manage, monitor, and optimize cell and gene therapy programs that improve personalized healthcare, regenerative medicine, therapeutic innovation, biomedical research, clinical excellence, healthcare quality, and digital healthcare transformation. The course combines expert-led presentations, laboratory demonstrations, practical simulation exercises, collaborative workshops, implementation projects, web-based tutorials, and real-world healthcare case studies to ensure participants develop immediately applicable scientific, technical, regulatory, and clinical competencies.

Course Objectives

1.     Understand the principles, technologies, and clinical applications of cell and gene therapy.

2.     Apply gene transfer technologies, genome editing, and cellular therapies in precision medicine.

3.     Understand stem cell biology, CAR-T cell therapy, and regenerative medicine concepts.

4.     Integrate cell and gene therapy with Electronic Health Records and healthcare information systems.

5.     Utilize artificial intelligence, bioinformatics, and genomic analytics in therapeutic development.

6.     Apply Good Manufacturing Practice (GMP) and quality management principles in therapy production.

7.     Strengthen biosafety, regulatory compliance, ethical governance, and patient safety.

8.     Evaluate clinical outcomes using evidence-based therapeutic approaches.

9.     Support translational research and personalized medicine through advanced therapeutic technologies.

10.  Develop organizational strategies for implementing enterprise cell and gene therapy programs.

Organizational Benefits

1.     Improved patient outcomes through advanced personalized therapies.

2.     Enhanced treatment options for cancer, rare diseases, and inherited genetic disorders.

3.     Accelerated translational research and biomedical innovation.

4.     Strengthened regenerative medicine and precision healthcare capabilities.

5.     Better integration of advanced therapeutic technologies with healthcare information systems.

6.     Improved laboratory quality management and manufacturing excellence.

7.     Enhanced compliance with GMP, GCP, biosafety, and international regulatory standards.

8.     Increased multidisciplinary collaboration in clinical care and biomedical research.

9.     Improved organizational reputation as a leader in advanced therapeutics.

10.  Enhanced institutional competitiveness through adoption of cutting-edge cell and gene therapy technologies.

Target Participants

This course is suitable for physicians, surgeons, oncologists, hematologists, geneticists, molecular biologists, laboratory scientists, biomedical researchers, pharmacists, biotechnology professionals, healthcare IT professionals, health informatics specialists, clinical researchers, hospital administrators, regulatory affairs professionals, quality assurance specialists, healthcare consultants, policymakers, project managers, postgraduate researchers, academic faculty, and professionals involved in regenerative medicine, precision medicine, genomic medicine, and advanced therapeutic development.

Course Outline

Module 1: Fundamentals of Cell and Gene Therapy

·       Introduction to cell therapy and gene therapy

·       Molecular genetics and cellular biology

·       Precision medicine and regenerative medicine principles

·       Gene transfer technologies and delivery systems

·       Clinical applications of advanced therapeutics

·       Case Study: Developing a cell and gene therapy strategy for a specialized healthcare institution

Module 2: Cell Therapy Technologies and Clinical Applications

·       Stem cell therapies and regenerative medicine

·       CAR-T cell therapy and immunotherapy

·       Cellular engineering techniques

·       Tissue regeneration and personalized therapeutics

·       Clinical trial design and therapeutic evaluation

·       Case Study: Implementing CAR-T cell therapy for hematological cancer treatment in a tertiary referral hospital

Module 3: Gene Therapy and Healthcare Systems Integration

·       Viral and non-viral gene delivery systems

·       CRISPR-Cas genome editing technologies

·       Bioinformatics and genomic data analysis

·       Electronic Health Records and Health Information Exchange integration

·       Artificial intelligence for clinical decision support

·       Case Study: Integrating gene therapy workflows into precision medicine and hospital information systems

Module 4: Governance, Manufacturing, and Regulatory Compliance

·       Good Manufacturing Practice (GMP) for cell and gene therapies

·       Good Clinical Practice (GCP) and clinical governance

·       Biosafety, bioethics, and patient consent

·       Regulatory frameworks and international standards

·       Quality assurance and risk management

·       Case Study: Establishing GMP-compliant manufacturing and governance systems for advanced therapy medicinal products

Module 5: Emerging Technologies in Cell and Gene Therapy

·       Artificial intelligence and machine learning applications

·       Digital twins and predictive therapeutic modeling

·       Three-dimensional bioprinting and organoid technologies

·       Blockchain-enabled healthcare data security

·       Cloud computing and precision healthcare analytics

·       Case Study: AI-supported gene therapy development for inherited neurological disorders and personalized treatment planning

Module 6: Enterprise Implementation and Future Innovations

·       Strategic planning for cell and gene therapy implementation

·       Organizational change management

·       Clinical outcome evaluation and performance monitoring

·       Emerging trends in regenerative medicine and advanced therapeutics

·       Sustainable innovation and digital healthcare transformation

·       Case Study: Enterprise-wide implementation of cell and gene therapy technologies to improve personalized healthcare, regenerative medicine, biomedical research, clinical excellence, operational efficiency, and organizational leadership

General Information

1.     Customized Training: All our courses can be tailored to meet the specific needs of participants.

2.     Language Proficiency: Participants should have a good command of the English language.

3.     Comprehensive Learning: Our training includes well-structured presentations, practical exercises, web-based tutorials, and collaborative group work. Our facilitators are seasoned experts with over a decade of experience.

4.     Certification: Upon successful completion of training, participants will receive a certificate from Foscore Development Center (FDC-K).

5.     Training Locations: Training sessions are conducted at Foscore Development Center (FDC-K) centers. We also offer options for in-house and online training, customized to the client's schedule.

6.     Flexible Duration: Course durations are adaptable, and content can be adjusted to fit the required number of days.

7.     Onsite Training Inclusions: The course fee for onsite training covers facilitation, training materials, two coffee breaks, a buffet lunch, and a Certificate of Successful Completion. Participants are responsible for their travel expenses, airport transfers, visa applications, dinners, health/accident insurance, and personal expenses.

8.     Additional Services: Accommodation, pickup services, freight booking, and visa processing arrangements are available upon request at discounted rates.

9.     Equipment: Tablets and laptops can be provided to participants at an additional cost.

10.  Post-Training Support: We offer one year of free consultation and coaching after the course.

11.  Group Discounts: Register as a group of more than two and enjoy a discount ranging from 10% to 50%.

12.  Payment Terms: Payment should be made before the commencement of the training or as mutually agreed upon, to the Foscore Development Center account. This ensures better preparation for your training.

13.  Contact Us: For any inquiries, please reach out to us at training@fdc-k.org or call us at +254712260031.

14.  Website: Visit www.fdc-k.org for more information.